Metabolic Effects of Egg Protein and Unsaturated Fat Intakes in Subjects With Hypertriglyceridemia
Metabolic Effects of Replacing Dietary Refined Carbohydrate With a Combination of Egg Protein and Unsaturated Fats in Men and Women With Elevated Triglycerides
1 other identifier
interventional
28
0 countries
N/A
Brief Summary
The goal of this study is to evaluate the effects of replacing some refined starches and added sugars with a combination of egg protein and unsaturated fatty acids on markers of cardiometabolic health in men and women with hypertriglyceridemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 3, 2016
CompletedFirst Posted
Study publicly available on registry
October 5, 2016
CompletedMay 15, 2018
May 1, 2018
1 year
October 3, 2016
May 11, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Matsuda composite index of insulin sensitivity (MISI)
Difference between treatments in percent change from baseline to end of treatment MISI calculated from glucose and insulin responses to the LMTT at Visit 2, Day 0 (baseline); Visit 6, Day 21 (end of treatment period I); and Visit 11, Day 21 (end of treatment period II)
3 weeks
Secondary Outcomes (7)
Lipoprotein lipids
3 weeks
Lipoprotein particle concentrations
3 weeks
Apolipoprotein (Apo) B
3 weeks
Homeostasis model assessment of insulin sensitivity (HOMA2-%S)
3 weeks
LMTT disposition index
3 weeks
- +2 more secondary outcomes
Study Arms (2)
Egg protein/unsaturated fatty acid
EXPERIMENTAL8% higher protein energy (from egg protein) and 8% higher fat energy (from unsaturated fatty acids); approximately 42/23/35% kcal from carbohydrate/protein/fat, respectively
Control
PLACEBO COMPARATOR16% higher carbohydrate energy; approximately 58/15/27% kcal from carbohydrate/protein/fat, respectively
Interventions
Study test foods (yogurt, muffins, waffles, and cookies) containing 8% higher protein energy (egg protein) and 8% higher fat energy (unsaturated fatty acids) than Control
Study test foods (yogurt, muffins, waffles, and cookies) containing 16% higher carbohydrate energy than Egg protein/unsaturated fatty acid
Eligibility Criteria
You may qualify if:
- Fasting TG level 150-499 mg/dL
- Body mass index (BMI) 25.0-39.9 kg/m2
- Score of 7-10 on Vein Access Scale
- Normally active and judged to be in general good health on basis of medical history and routine laboratory tests
You may not qualify if:
- Fasting blood glucose ≥126 mg/dL or known type 1 or type 2 diabetes mellitus
- Atherosclerotic cardiovascular disease
- Recent history or current significant renal, pulmonary, hepatic, biliary, or gastrointestinal disease
- Abnormal lab test results of clinical significance (e.g., creatinine ≥1.5 mg/dL and aspartate or alanine transaminase ≥1.5 times upper limit of normal)
- History of cancer in previous 2 years
- Uncontrolled hypertension
- Recent unstable use of anti-hypertensive medication, thyroid hormone replacements, and/or medications known to substantially influence carbohydrate metabolism
- Recent use of certain blood pressure medications (e.g., beta-adrenergic blockers and/or high-dose thiazide diuretics)
- Recent use of lipid-altering drugs (e.g., statins, bile acid sequestrants, cholesterol absorption inhibitors, or fibrates)
- Recent use of diabetes medication (e.g., alpha-glucosidase inhibitors, biguanides and biguanide combinations, bile acid sequestrants, thiazolidinediones, dipeptidyl peptidase-4 inhibitors, meglitinides, and sulfonylureas and combination sulfonylureas)
- Recent use of lipid-altering foods, herbs, or dietary supplements (e.g., niacin, sterol/stanol products, dietary fiber supplements, red rice yeast supplements)
- Recent unstable use of herbs and dietary supplements that may influence carbohdyrate metabolism
- Extreme dietary habits, dietary restrictions, or significant food allergies
- Required energy intake \<2200 kcal/day or \>3400 kcal/day
- Recent change in body weight of ±4.5 kg
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Midwest Center for Metabolic and Cardiovascular Researchlead
- American Egg Boardcollaborator
- Egg Nutrition Centercollaborator
Related Publications (1)
Maki KC, Palacios OM, Lindner E, Nieman KM, Bell M, Sorce J. Replacement of Refined Starches and Added Sugars with Egg Protein and Unsaturated Fats Increases Insulin Sensitivity and Lowers Triglycerides in Overweight or Obese Adults with Elevated Triglycerides. J Nutr. 2017 Jul;147(7):1267-1274. doi: 10.3945/jn.117.248641. Epub 2017 May 17.
PMID: 28515160DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin C Maki, PhD
Midwest Center for Metabolic and Cardiovascular Research
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2016
First Posted
October 5, 2016
Study Start
February 1, 2015
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
May 15, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share